皮膚科治療薬市場- 世界の産業規模、シェア、動向、機会、予測、用途別、薬剤クラス別、地域別、競合別、2020-2030F

皮膚科治療薬市場は、2024年に218億米ドルと評価され、2030年には352億5,000万米ドルに達し、CAGR 8.30％で成長すると予測されています。

この市場には、にきびや湿疹のような一般的な疾患から乾癬や皮膚がんのような重篤な疾患まで、皮膚、毛髪、爪、粘膜に影響を及ぼす疾患の診断と治療が含まれます。皮膚疾患の有病率の増加、皮膚の健康に対する意識の高まり、生物学的製剤や個別化医療における技術の進歩により、皮膚科治療に対する需要は高まっています。世界的に高齢化が進み、美容への関心が高まるにつれて、医療・美容両方の皮膚治療への関心が高まっています。特に新興市場における可処分所得の拡大も、皮膚科医療への幅広いアクセスを可能にしています。医薬品イノベーションとデジタルヘルス動向は、皮膚科疾患の診断・管理方法を再構築し、同分野の持続的成長を促進する態勢を整えています。

市場促進要因

皮膚疾患の有病率の上昇

主な市場課題

ジェネリック医薬品の競合

主要市場動向

個別化医療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 皮膚科治療薬市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（脱毛症、ヘルペス、乾癬、酒さ、アトピー性皮膚炎、その他）
  • 薬剤クラス別（抗感染症薬、コルチコステロイド、抗ニキビ薬、カルシニューリン阻害剤、レチノイド、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の皮膚科治療薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の皮膚科治療薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の皮膚科治療薬市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の皮膚科治療薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの皮膚科治療薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の皮膚科治療薬市場：SWOT分析

第14章 競合情勢

• Abbvie Inc.（Allergan PLC）
• Almirall SA
• Amgen Inc.
• Bausch Health Companies Inc.
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Dermatological Therapeutics Market was valued at USD 21.80 billion in 2024 and is projected to reach USD 35.25 billion by 2030, growing at a CAGR of 8.30%. This market encompasses the diagnosis and treatment of conditions affecting the skin, hair, nails, and mucous membranes, including common ailments like acne and eczema, as well as serious diseases such as psoriasis and skin cancer. Demand for dermatological treatments is rising due to the growing prevalence of skin disorders, increasing awareness around skin health, and technological advances in biologics and personalized medicine. As the global population ages and aesthetic concerns gain prominence, the market is experiencing heightened interest in both medical and cosmetic skin therapies. Expanding disposable incomes, particularly in emerging markets, are also enabling broader access to dermatological care. Pharmaceutical innovations and digital health trends are poised to reshape how dermatological conditions are diagnosed and managed, driving sustained growth in the sector.

Key Market Drivers

Rising Prevalence of Skin Disorders

The increasing global burden of skin diseases is a primary driver of the Dermatological Therapeutics Market. Skin disorders affect approximately 1.8 billion people worldwide, with estimates suggesting that 30% to 70% of the population experiences some form of dermatological condition at any given time. This widespread prevalence underscores a strong, sustained demand for effective skin treatments. Common conditions such as acne, eczema, psoriasis, atopic dermatitis, rosacea, and various infections are becoming more frequent across all age groups. This expanding patient pool presents a significant opportunity for pharmaceutical companies to develop and market innovative dermatological solutions. Additionally, growing awareness of skin health, driven by social media and increasing focus on aesthetics, further boosts demand for both therapeutic and cosmetic dermatology products. The persistent rise in skin disease incidence makes dermatology one of the most essential and dynamic sectors in healthcare, reinforcing its critical role in global medical infrastructure.

Key Market Challenges

Generic Competition

Generic competition poses a significant challenge to branded pharmaceutical companies operating in the dermatological therapeutics space. Once the patent protection for a drug expires, generic alternatives enter the market, often at significantly lower prices. This price disparity leads to erosion of market share and revenue for original branded products. The transition to generics intensifies pricing pressures, driving down profit margins and fragmenting the market with numerous similar products. Healthcare providers and insurers increasingly favor generics to reduce treatment costs, further impacting demand for branded therapies. For patients and dermatologists, a growing array of generic options can create confusion and complicate prescribing decisions. As the volume of generics increases, innovation may slow due to reduced financial incentives for R&D in new dermatological treatments, challenging companies to maintain competitiveness in a cost-sensitive environment.

Key Market Trends

Personalized Medicine

Personalized medicine is reshaping the landscape of dermatological therapeutics by offering targeted, individualized treatment approaches based on a patient's genetic profile, biomarkers, and disease characteristics. Advances in genomics enable the identification of genetic markers linked to specific skin conditions, such as psoriasis or melanoma, leading to tailored therapeutic interventions. Biomarker analysis allows dermatologists to predict patient responses to certain drugs and monitor disease progression more accurately. The use of biologics and small molecule inhibitors designed to target specific disease pathways has significantly improved outcomes for patients with severe dermatological conditions. Additionally, customized topical formulations-developed in collaboration with compounding pharmacies-address individual needs related to skin type and sensitivities. Personalized medicine also enhances risk stratification and prevention strategies for skin cancers and chronic inflammatory skin diseases. This trend is driving better clinical results, minimizing side effects, and marking a shift toward more effective and proactive dermatological care.

Key Market Players

• Abbvie Inc. (Allergan PLC)
• Almirall SA
• Amgen Inc.
• Bausch Health Companies Inc.
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company

Report Scope:

In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatological Therapeutics Market, By Application:

• Alopecia
• Herpes
• Psoriasis
• Rosacea
• Atopic Dermatitis
• Other

Dermatological Therapeutics Market, By Drug Class:

• Anti-infectives
• Corticosteroids
• Anti-acne
• Calcineurin Inhibitors
• Retinoids
• Other

Dermatological Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.

Available Customizations:

Global Dermatological Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Dermatological Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Other)
  • 5.2.2. By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Dermatological Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Drug Class
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermatological Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Drug Class
  • 6.3.2. Canada Dermatological Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Drug Class
  • 6.3.3. Mexico Dermatological Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Drug Class

7. Europe Dermatological Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Drug Class
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermatological Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Drug Class
  • 7.3.2. United Kingdom Dermatological Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Drug Class
  • 7.3.3. Italy Dermatological Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Drug Class
  • 7.3.4. France Dermatological Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Drug Class
  • 7.3.5. Spain Dermatological Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Drug Class

8. Asia-Pacific Dermatological Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Drug Class
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Dermatological Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Drug Class
  • 8.3.2. India Dermatological Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Drug Class
  • 8.3.3. Japan Dermatological Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Drug Class
  • 8.3.4. South Korea Dermatological Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Drug Class
  • 8.3.5. Australia Dermatological Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Drug Class

9. South America Dermatological Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Drug Class
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Dermatological Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Drug Class
  • 9.3.2. Argentina Dermatological Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Drug Class
  • 9.3.3. Colombia Dermatological Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Drug Class

10. Middle East and Africa Dermatological Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Drug Class
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Dermatological Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Drug Class
  • 10.3.2. Saudi Arabia Dermatological Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Drug Class
  • 10.3.3. UAE Dermatological Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Drug Class

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Dermatological Therapeutics Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbvie Inc. (Allergan PLC)
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Almirall SA
• 14.3. Amgen Inc.
• 14.4. Bausch Health Companies Inc.
• 14.5. Galderma SA
• 14.6. GlaxoSmithKline PLC
• 14.7. Johnson & Johnson
• 14.8. Novartis AG
• 14.9. Pfizer Inc.
• 14.10.Bristol-Myers Squibb Company.

15. Strategic Recommendations

16. About Us & Disclaimer